BrightGene Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BrightGene Bio stock prices and determine the direction of BrightGene Bio Medical's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of BrightGene Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
BrightGene
At present, BrightGene Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 26.6 M, whereas Total Stockholder Equity is forecasted to decline to about 1.4 B.
On January 10, 2025 BrightGene Bio Medical had Day Median Price of 29.36. Median Price is the statistical median of an asset price for a given trading period.
On January 13 2025 BrightGene Bio Medical was traded for 28.87 at the closing time. The highest price during the trading period was 29.20 and the lowest recorded bid was listed for 28.45 . The volume for the day was 3.6 M. This history from January 13, 2025 contributed to the next trading day price decline. The daily price change to the next closing price was 0.48% . The overall trading delta to the current price is 2.21% .
The median price is the midpoint of the trading periods range.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BrightGene Bio stock to make a market-neutral strategy. Peer analysis of BrightGene Bio could also be used in its relative valuation, which is a method of valuing BrightGene Bio by comparing valuation metrics with similar companies.
Market strength indicators help investors to evaluate how BrightGene Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BrightGene Bio shares will generate the highest return on investment. By undertsting and applying BrightGene Bio stock market strength indicators, traders can identify BrightGene Bio Medical entry and exit signals to maximize returns.
The analysis of BrightGene Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BrightGene Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting brightgene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Other Information on Investing in BrightGene Stock
BrightGene Bio financial ratios help investors to determine whether BrightGene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BrightGene with respect to the benefits of owning BrightGene Bio security.